BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Map Kinase Kinase Kinase 2

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Map Kinase Kinase Kinase 2:

Pubmed Logo
MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation.
Melatonin induces cellular differentiation in numerous cell types. Data...
3rd May, 2008
Division of Pharmaceutical Sciences, School of Pharmacy, Duquesne J Pineal Res. 2008 Apr;44(3):288-98.
DOI Direct Link
(-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
We previously reported that prostaglandin D2 (PGD2) stimulates heat shock...
15th February, 2008
Department of Pharmacology, Gifu University Graduate School of Medicine, Prostaglandins Leukot Essent Fatty Acids. 2007 Oct-Nov;77(3-4):173-9. Epub
DOI Direct Link
Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling.
MEKK2 and MEK5 encode Phox/Bem1p (PB1) domains that heterodimerize with...
10th July, 2007
Department of Pharmacology, 1108 Mary Ellen Jones Building, University of Mol Cell Biol. 2007 Jun;27(12):4566-77. Epub 2007 Apr 23.
DOI Direct Link
Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase.
BACKGROUND: Recruitment of macrophages is crucial to the pathogenesis of...
30th June, 2007
Department of Dentistry, National Taiwan University Hospital, Taiwan. Am J Rhinol. 2007 Mar-Apr;21(2):251-5.
Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway.
Epidemiologic studies have suggested an inverse correlation between...
8th June, 2007
Department of Community, Occupational, and Family Medicine, Yong Loo Lin Mol Cancer Ther. 2006 Dec;5(12):3285-93.
DOI Direct Link

View more research publications.

BioPortfolio Ltd. offers e-mail and postal lists for Map Kinase Kinase Kinase 2 scientists - we have details of around 6 individuals working on Map Kinase Kinase Kinase 2 .


This page has been viewed 53 times Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Map Kinase Kinase Kinase 2 across BioPortfolio, or bestselling Map Kinase Kinase Kinase 2 books or recently published Map Kinase Kinase Kinase 2 books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional